Catherine P. Langford

Increased efficacy of an interleukin-12-secreting herpes simplex virus ina syngeneic intracranial murine glioma model

Elizabeth K. Hellums, James M. Markert, Jacqueline N. Parker et al. · Neuro-Oncology · 2005 · 122 citations · Full text

Medicine, Immunology, Oncology +13

Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma

Braden C. McFarland, Jingyuan Ma, Catherine P. Langford et al. · Molecular Cancer Therapeutics · 2011 · 88 citations · Full text

Medicine, Oncology, Pharmacology +16

Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111

Gregory K. Friedman, Catherine P. Langford, Jennifer Coleman et al. · Journal of Neuro-Oncology · 2009 · 75 citations · Full text

Life Sciences, Cell Biology, Oncology +12

Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression

Gregory K. Friedman, Joshua D. Bernstock, Dongquan Chen et al. · Scientific Reports · 2018 · 75 citations · Full text

Medicine, Oncology, Pediatrics +16

Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses

Gregory K. Friedman, Blake P. Moore, Li Nan et al. · Neuro-Oncology · 2015 · 66 citations · Full text

Medicine, Oncology, Pediatrics +17